Xeris Biopharma Holdings XERS
NASDAQ XERS
$10.86 +0.08 (+0.74%)
At close: Oct 22, 2026 · 4:00 PM EDT

Xeris Biopharma Holdings (XERS) Other non-cash items (2020 - 2026)

Updated

Analysis

Xeris Biopharma Holdings (XERS) Other non-cash items (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Xeris Biopharma Holdings 1.89 Bn 1.45 Bn 79.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30.78 Mn
Mar 31, 2026 163,000.00
Dec 31, 2025 151,000.00
Sep 30, 2025 140,000.00
Mar 31, 2025 118,000.00
Dec 31, 2024 109,000.00
Jun 30, 2024 163,000.00
Mar 31, 2024 177,000.00
Dec 31, 2023 202,000.00
Sep 30, 2023 2.84 Mn
Jun 30, 2023 267,000.00
Mar 31, 2023 106,000.00
Dec 31, 2022 426,000.00
Jun 30, 2022 -100,000.00
Mar 31, 2022 1.32 Mn
Sep 30, 2021 -81,000.00
Dec 31, 2020 -2.18 Mn
Sep 30, 2020 160,000.00
API Access

Xeris Biopharma Holdings Other non-cash items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=XERS&period=max&api_key=YOUR_API_KEY